AAO 2007: Updates on Presby-IOLs and AMD Therapies

The buzz at this year's annual meeting of the American Academy of Ophthalmology focused on two things: the presbyopia-correcting intraocular lens market, and the controversy surrounding the drugs Lucentis and Avastin for treating wet age-related macular degeneration.

by Michael Lachman

The American Academy of Ophthalmology (AAO) held its 2007 Annual Meeting and Subspecialty Days in New Orleans November 9-13, 2007....

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight